Kestra Advisory Services LLC Acquires 5,155 Shares of iShares Biotechnology ETF $IBB

Kestra Advisory Services LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 47,461 shares of the financial services provider’s stock after acquiring an additional 5,155 shares during the period. Kestra Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $8,014,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the second quarter valued at $25,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at $26,000. Cary Street Partners Financial LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at $29,000. Copia Wealth Management purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter worth about $34,000. Finally, Caitlin John LLC purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter worth about $34,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Down 1.3%

Shares of iShares Biotechnology ETF stock opened at $189.58 on Tuesday. The firm’s 50-day moving average is $176.32 and its 200 day moving average is $172.93. iShares Biotechnology ETF has a 1 year low of $128.84 and a 1 year high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were paid a $0.0238 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.